About ScreenPoint Medical
ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis. They exploit the latest methods in the rapidly evolving field of machine learning, combining these with very large, well-curated digital image databases and a thorough understanding of the physics of mammogram image formation and the practicalities of the clinical deployment of mammographic image analysis.
Company details
Funding
Total raised
$49M
Last stage
Series C
Investors
Founders
Nico Karssemeijer
Professor of Computer-Aided Diagnosis at Radboud University in the Netherlands; world-leading expert in quantitative breast image analysis and computer-aided detection; co-founded ScreenPoint Medical in 2014 as a spin-off from Radboud University Medical Centre.
LinkedInMichael Brady
Professor Sir Michael Brady; emeritus professor of the Department of Oncology at the University of Oxford; world-leading expert in breast image analysis and computer-aided detection; elected to the US National Academy of Engineering (Class of 2026).
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.